Aaron H. J. and Schwartz W. B. (1984), The Painful Prescription, Washington, DC: Brookings Institution.
Aaron H. J., Schwartz W. B. and Cox M. (2005), Can We Say No? The Challenge of Rationing Health Care, Washington, DC: Brookings Institution.
Anderson G. F., Reinhardt U. E., Hussey P. S. and Petrosyan V. (2003), ‘It’s the prices, stupid: why the United States is so different from other countries’, Health Affairs, 22(3): 89–105.
Anderson G. F., Hussey P. S., Frogner B. K. and Waters H. R. (2005), ‘Health spending in the United States and the rest of the industrialized world’, Health Affairs, 24: 903–914.
Arrow K. J. (1963), ‘Uncertainty and the welfare economics of medical care’, American Economic Review, 53: 941–973.
Barr N. and Diamond P. (2006), ‘The Economics of Pensions’, Oxford Review of Economic Policy, 22(1): 15–39.
Barer M. L., Evans R. G., Hertzman C. and Lomas J. (1987), ‘Aging and health care utilization: new evidence on old fallacies’, Social Science and Medicine, 24(10): 851–862.
Beech R., Bevan G. and Mays N. (1990), ‘Spatial equity in the NHS: the death and rebirth of RAWP’, in Harrison A. (ed.) Health Care UK 1990, Newbury: Policy Journals, 44–61.
Bernstein N. (2012), ‘With Medicaid, Long-Term Care of Elderly Looms as Rising Cost’, New York Times, 7 September.
Bevan A. (1978), In Place of Fear, London: Quartet.
Bevan G. (2009), ‘The search for a proportionate care law by formula funding in the English NHS’, Financial Accountability and Management, 25(1): 391–410.
Bevan G. and Hood C. (2006), ‘What’s measured is what matters: targets and gaming in the English public health care system’, Public Administration, 84(3): 517–538.
Bevan G. and Robinson R. (2005), ‘The interplay between economic and political logics: path dependency in health care in England’, Journal of Health Politics, Policy and Law, 30(1–2): 53–78.
Brown L. D. (2011), ‘The elements of surprise: how health reform happened’, Journal of Health Politics, Policy and Law, 36(3): 419–427.
Brown L. D. (2012a), ‘The fox and the grapes: is real reform beyond reach in the United States?’ Journal of Health Politics, Policy and Law, 37(4): 587–609.
Brown L. D. (2012b), ‘Stealing On Insensibly’: end-of-life politics in the United States’, Health Economics, Policy and Law, 7(4): 467–483.
Claxton K., Martin S., Soares M., Rice N., Spackman E., Hinde S., Devlin N., Smith P. C. and Sculpher M. (2013), Methods for the Estimation of the NICE Cost Effectiveness Threshold. Centre for Health Economics, University of York, CHE Research Paper, p. 81. http://www.york.ac.uk/media/che/documents/papers/researchpapers/CHERP81_methods_estimation_NICE_costeffectiveness_threshold_%28Nov2013%29.pdf [30 March 2014].
Connolly S., Bevan G. and Mays N. (2011), Funding and Performance of Healthcare System in the Four Countries of the UK Before and After Devolution, London: Nuffield Trust for Research and Policy Studies in Health Services.
Daniels N. (1990), Just Health Care, Cambridge: Cambridge University Press.
Daniels N. (2003), ‘Democratic equality: Rawls’s complex egalitarianism’, in S. Freeman (ed.) The Cambridge Companion to Rawls, Cambridge: Cambridge University Press, 241–276.
Dworkin R. (1992), ‘Justice in the distribution of health care’, McGill Law Journal, 38: 883–898.
Dworkin R. (2000), Sovereign Virtue: The Theory and Practice of Equality, London: Harvard University Press.
Eichner J. and Vladeck B. C. (2005), ‘Medicare as a catalyst for reducing health disparities’, Health Affairs, 24(2): 365–375.
Evans R. G. (1987), ‘Public health insurance: the collective purchase of individual care’, Health Policy, 7: 115–134.
Faden R. R. and Chalkidou K. (2011), ‘Determining the value of drugs – the evolving British experience’, The New England Journal of Medicine, 364: 1289–1291.
Fradkin J. E. (2012), ‘Confronting the urgent challenge of diabetes: an overview’, Health Affairs, 31(1): 12–19.
Gottlieb D. J., Zhou W., Song Y., Andrews K. G., Skinner J. S. and Sutherland J. M. (2010), ‘Prices don’t drive regional Medicare spending variations’, Health Affairs, 29(3): 537–543.
Gray B. H. (2011), England’s Approach to Improving End-of-Life Care: A Strategy for Honoring Patients’ Choices, New York: Commonwealth Fund.
House of Commons, Public Accounts Committee (2009), End of Life Care. Nineteenth Report of Session 2008–09, London: Stationary Office.
Jost T. S. (2014), ‘Implementing health reform: four years later’, Health Affairs, 33(1): 7–10.
Judge A., Welton N. J., Sandhu J. and Ben-Shlomo Y. (2010), ‘Equity in access to total joint replacement of the hip and knee in England: cross sectional study’, BMJ, 341: c4092.
Kaiser Family Foundation (2011), Medicare Spending and Financing, Washington, DC: The Henry J. Kaiser Family Foundation.
Klein R. (2010), The New Politics of the NHS: From Creation to Reinvention, 6th edition, London: Radcliffe.
Klein R. and Maybin J. (2012), Thinking About Rationing, London: King’s Fund.
Marmor T. (2000), The Politics of Medicare, second edition, New York: Aldine de Gruyter.
Marmor T. (2012), ‘American health care policy and politics’, in T. R. Marmor and R. Klein (eds), Politics Health and Health Care, London: Yale University Press, 37–52.
Marmor T. and McKissick G. J. (2012), ‘Medicare’s future’, in T. R. Marmor and R. Klein (eds), Politics Health and Health Care, London: Yale University Press, 53–88.
Morgan S. and Kennedy J. (2010), Prescription Drug Accessibility and Affordability in the United States and Abroad, New York: The Commonwealth Fund.
Neumann P. J. and Weinstein M. C. (2010), ‘Legislating against use of cost-effectiveness information’, New England Journal of Medicine, 363: 1495–1497.
Newhouse J. P. (1993), ‘An iconoclastic view of health cost containment’, Health Affairs, 12(Supplement): 152–171.
Owen-Smith A., Kipping R., Donovan J., Hine C., Maslen C. and Coast J. (2013), ‘A NICE example? Variation in provision of bariatric surgery in England’, BMJ, 346: f2453.
Reinhardt U. E., Hussey P. S. and Anderson G. F. (2004), ‘U.S. health care spending in an international context’, Health Affairs, 23: 310–325.
Secretary of State for Health (2010), Equity and Excellence: Liberating the NHS. Cm7881, London: Department of Health.
Skinner J. (2011), ‘Understanding prices and quantities in the US health care system’, Journal of Health Politics, Policy and Law, 36(4): 791–801.
Smith S., Newhouse J. P. and Freeland M. S. (2009), ‘Income, insurance, and technology: why does health spending outpace economic growth?’ Health Affairs, 28: 1276–1284.
Sochalski J., Jaarsma T., Krumholz H. M., Laramee A., McMurray J. J., Naylor M. D., Rich M. W., Riegel B. and Stewart S. (2009), ‘What works in chronic care management: the case of heart failure’, Health Affairs, 28: 179–189.
Steinbrook R. (2008), ‘Saying no isn’t NICE – the travails of Britain’s National Institute for Health and Clinical Excellence’, New England Journal of Medicine, 359: 1977–1981.
Thorlby R. and Maybin J. (2010), A High-Performing NHS? A Review of Progress 1997–2010, London: The King’s Fund.
Timmins N. (2012), Never Again? The story of the Health and Social Care Act 2012, London: King’s Fund and Institute for Government.
Tuohy C. (1999), Accidental Logics. The Dynamics of Change in the Health Care Arena in the United States, Britain and Canada, New York: Oxford University Press.
Webster C. (1988), The Health Services Since the War. Volume I. Problems of the National Health Service Before 1957, London: HMSO.
Webster C. (ed.) (1991), Aneurin Bevan on the National Health Service, Oxford: University of Oxford.
Williams A. (1985), ‘The economics of coronary artery bypass grafting’, BMJ, 291: 326–329.
Williams A. (1997), ‘Equity: intergenerational equity: an exploration of the ‘fair innings’ argument’, Health Economics, 6(2): 117–132.
Wolff J. L., Starfield B. and Anderson G. (2002), ‘Prevalence, expenditures, and complications of multiple chronic conditions in the elderly’, Archives of Internal Medicine, 162: 2269–2276.
Zweifel P., Felder S. and Meiers M. (1999), ‘Ageing of population and health care expenditure: a red herring?’, Health Economics, 8(6): 485–496.